Listing provided by the MCOM Office of Research:
Research Project Grant (Parent R01 Clinical Trial Required) (PA-19-055)
Application Receipt/Submission Date(s): Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) (PA-19-056)
Application Receipt/Submission Date(s): Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) (PA-19-053)
Application Receipt/Submission Date(s): Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) (PA-19-054)
Application Receipt/Submission Date(s): Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
New Research Directions that Advance the NHLBI Strategic Vision Normal Biology (R21 – Clinical Trial Not Allowed) PA-19-049
Application Due Date: Standard Dates, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Promoting Research on Music and Health: Fundamentals and Applications (R01 Clinical Trials Optional) RFA-NS-19-008 Letter of Intent Due Date: Jan. 15, 2019 (NOT REQUIRED) Application Due Date: Feb. 28, 2019, by 5 p.m. local time of applicant organization. No late applications will be accepted for this Funding Opportunity Announcement.
Promoting Research on Music and Health: Fundamentals and Applications (R21 Clinical Trials Optional) RFA-NS-19-009
Letter of Intent Due Date: Jan. 15, 2019 (NOT REQUIRED)
Application Due Date: Feb. 28, 2019, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33, Clinical Trial Optional) RFA-AT-19-001
Letter of Intent Due Date: Jan. 15, 2019 (NOT REQUIRED)
Application Due Date: Feb. 28, 2019, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Alzheimer’s Disease Research Centers (P30 Clinical Trial Not Allowed) (RFA-AG-20-004) National Institute on Aging
Application Receipt Date(s): April 25, 2019, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) (RFA-MH-19-235) National Institute of Mental Health
Application Receipt Date(s): Feb. 4, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01 Clinical Trial Not Allowed) (RFA-CA-19-015)
Application Receipt Date(s): Feb. 8, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01 Clinical Trial Not Allowed) (RFA-CA-19-014)
Application Receipt Date(s): Feb. 8, 2019, by 5 p.m local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Lymphatics in Health and Disease in the Digestive System (R01 Clinical Trial Not Allowed) (RFA-DK-18-021)
Application Receipt Date(s): Feb. 21, 2019, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional) (RFA-MH-19-400)
Application Receipt Date(s): Feb. 4, 2019, Oct. 9, 2019 and Oct. 9, 2020, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.
NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00) (RFA-NS-19-011)
Application Receipt Date(s): April 15, 2019; December 13, 2019; April 15, 2020; December 15, 2020; April 15, 2021 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Research on Chronic Overlapping Pain Conditions (R01 Clinical Trial Optional) (PA-18-937)
Application Receipt/Submission Date(s): Standard dates, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Research on Chronic Overlapping Pain Conditions (R21 Clinical Trial Not Allowed) (PA-18-939)
Application Receipt/Submission Date(s): Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
